Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-23

FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approves Aurohealth LLC's generic fexofenadine hydrochloride (oral) under Orig AP; indicated for allergic rhinitis and chronic idiopathic urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine hydrochloride (oral) (Fexofenadine hydrochloride)

Snippet

ORIG AP for FEXOFENADINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE ORAL)